Journal of Tissue Viability
We believe that skin health and wound healing is everyone’s business and that change happens when we work together, not in silos.
About the Journal of Tissue Viability
Ever since its beginnings the Society of Tissue Viability (formerly the Tissue Viability Society / TVS) has published a scientific and clinical journal – in its first format this was called Care – Science and Practice (issued from 1981 to 1990). In 1990 the journal was renamed the Journal of Tissue Viability. Indexed in MEDLINE, PubMed, CINAHL, AMED and EMBASE this quarterly publication features a range of peer-reviewed papers. Full-text articles are available on Science Direct.
The Journal of Tissue Viability is the official publication of the Society of Tissue Viability and has been published by Elsevier since January 2008. This journal, indexed in several electronic databases, covers all aspects of the growing field of Tissue Viability. Each issue contains a mix of publications ranging from systematic reviews, reports of randomised controlled trials, laboratory studies, case series and individual patient histories. The Impact Factor of this journal is 2.4.
The Journal of Tissue Viability currently has 28 editors and editorial board members in 13 countries / regions.
The Journal is changing
The Society are immensely proud of the Journal of Tissue Viability (JTV), a peer reviewed journal with a current impact factor of 2.4. The journal has been published and printed quarterly since 1990 with a copy/ies being sent by post to each Society member and industry partners.
Traditionally, The JTV has been made up of both subscription only and open access articles, although the trend to open access has been increasing year on year (37% in 2023) and general market trends suggest this will continue to accelerate.
We are therefore delighted to share our news that, further to careful consideration, and a lengthy consultation by Trustees with members, the publisher, editor and editorial board, the JTV will change to gold open access on 1 October 2024 and will be available in digital form only from 1 January 2025.
This positive move brings a huge range of benefits to the Society and its members.
Editorial board
The scientific and clinical content of the Journal of Tissue Viability is managed by an Editor and prominent Editorial Board, with all submitted manuscripts subject to review by at least two referees.
Journal Manager
R. Kumar Jayakumar
Current and back issues
If you are a member of the Society of Tissue Viability, you access the Journal by using the following steps. It is a one-time process to activate your online subscription at ScienceDirect, Elsevier’s flagship platform for peer-reviewed scholarly literature:
- Provide a customer reference number to validate your online subscription
Go to www.sciencedirect.com/science/activate/tvs, Enter your Customer Reference number and click Continue. - Connect your membership identifier to a personal login
If you have previously registered with Elsevier, enter your username and password to Login, if you are a new user, click Register Now and complete a brief registration form.
Once login/registration is complete, you will return to the ScienceDirect homepage and can use the Journal/Book title search box to access your subscription.
You can bookmark sciencedirect.com/journal/journal-of-tissue-viability and save time accessing your subscription on future visits.
Want to become a peer reviewer of the Journal of Tissue Viability?
Anyone with skills and understanding in the field of Tissue Viability can become a peer reviewer, whether you are a nurse, allied health professional, researcher or academic.
